The pattern no single source sees

Search

Stories, the companies and people Loro tracks, and the primary records behind them — filings, donations, contracts and disclosures.

Company or person7

NUTRA PHARMA CORP

Company

4 records in the corpus

Phio Pharmaceuticals Corp.

Company

16 records in the corpus

NUCOR CORP

Company

7 records in the corpus

Arbutus Biopharma Corp

Company

17 records in the corpus

Nuvectis Pharma, Inc.

Company

2 records in the corpus

Vistra Corp.

Company

11 records in the corpus

Cocrystal Pharma, Inc.

Company

6 records in the corpus

Primary record4

NUTRA PHARMA CORP filed 8-K

Item 5.01. Changes in Control of Registrant. On August 21, 2026, Rik Deitsch transferred twelve million (12,000,000) shares of the Company s Series B Preferred Stock to Pure Raw Supplies, LLC as a gift and for no conside

02 Sep 2026 · sec daily index

NUTRA PHARMA CORP filed SCHEDULE 13D

0001493152-26-041007.txt : 20260901 SCHEDULE 13D 1 primary_doc.xml X0202 SCHEDULE 13D 0002151473 XXXXXXXX LIVE Series B Preferred Shares 08/21/2026 false 0001119643 67060U208 Nutra Pharma Corp 6400 Park of Commerce Blvd

01 Sep 2026 · sec daily index

NUTRA PHARMA CORP filed 4

SEC form 4 filed by NUTRA PHARMA CORP (CIK 1119643) on 2026-09-01.

01 Sep 2026 · sec daily index

NUTRA PHARMA CORP filed NT 10-Q

WASHINGTON D.C. 20549 FORM 12b-25 NOTIFICATION OF LATE FILING (Check One) ☐ Form 10-K ☐ Form 20-F ☐ Form 11-K ☒ Form 10-Q ☐ Form N-SAR ☒ For Period Ended: June 30, 2026 ☐ Transition Report on Form 10-K ☐ Transition Repor

14 Aug 2026 · sec daily index